A Real-world Study of Patients With Hidradenitis Suppurativa and High Cardiovascular Risk or Established Coronary Plaque Treated With Secukinumab
Clinical trial NCT07454889 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07454889
- Sponsor
- Novartis Pharmaceuticals
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-07-31
- Primary completion
- 2027-03-31
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.